Femara (letrozole) or Arimidex (anastrozole) for breast cancer

February 2001

You'll see more women taking Femara (letrozole) or Arimidex (anastrozole) for breast cancer.

Both are now approved for INITIAL therapy of metastatic breast cancer...as an alternative to tamoxifen.

Until now, tamoxifen was the gold standard for treating women with estrogen-receptor positive breast cancer. But Femara and Arimidex seem to work at least as well...if not better.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote